Ftse Mib
34.127,62
-0,72%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
97.852,37
-0,36%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Veracyte Inc (VCYT) Veracyte Inc (VCYT) Notizie

Veracyte Inc

VCYT
41,95
1,51 (3,73%)
04 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/12/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202422:27EDGAR2Form 144 - Report of proposed sale of securities
06/12/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202423:24EDGAR2Form 144 - Report of proposed sale of securities
05/12/202422:05BWVeracyte’s Decipher Prostate Test Is Now the Only Gene..
04/12/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:38EDGAR2Form 144 - Report of proposed sale of securities
04/12/202422:35EDGAR2Form 144 - Report of proposed sale of securities
03/12/202422:32EDGAR2Form 144 - Report of proposed sale of securities
03/12/202422:31EDGAR2Form 144 - Report of proposed sale of securities
29/11/202420:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202422:29EDGAR2Form 144 - Report of proposed sale of securities
12/11/202415:30EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202414:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:11EDGAR2Form 8-K - Current report
06/11/202422:05BWVeracyte Announces Third Quarter 2024 Financial Results
30/10/202422:00BWVeracyte to Participate in Upcoming Investor Conferences
17/10/202400:43BWVeracyte to Release Third Quarter 2024 Financial Results on..
02/10/202414:20BWNew Data Presented at ASTRO 2024 Show that Veracyte’s..
15/9/202414:45BWNew Data Presented at ESMO 2024 Show that Veracyte’s..
06/9/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202402:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202402:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202400:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202422:17EDGAR2Form 144 - Report of proposed sale of securities
04/9/202422:14EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/9/202422:14EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/9/202422:10EDGAR2Form 8-K - Current report
04/9/202422:05BWVeracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its..
26/8/202423:30BWVeracyte to Participate in the Morgan Stanley 22nd Annual..
26/8/202415:00BWVeracyte Named a Greater Bay Area Top Workplace by the San..
09/8/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202414:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:16EDGAR2Form 8-K - Current report
06/8/202422:05BWVeracyte Announces Second Quarter 2024 Financial Results
19/7/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202423:00BWVeracyte to Release Second Quarter 2024 Financial Results on..
16/7/202422:32EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 40,50 Min: 40,24 Max: 41,95
Chiusura: 40,44

La tua Cronologia

NASDAQ
VCYT
Veracyte
BIT
EUNO
ETFS Long NOK Short EUR
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network